SUBVENITE
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 06 Jun 2025)
What this means for you
Registered since 12 Feb 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87690016
- Registration number
- 5676310
- Mark type
- Stylized text
- Filed
- 17 Nov 2017
- Published for opposition
- 10 Apr 2018
- Registered
- 12 Feb 2019
- Attorney of record
- Kenneth S. McLaughlin, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of epilepsy and bipolar disorder
Owner
- ROWP IP HOLDING COMPANY, LLC, Lisle, IL, US
- OWP Pharmaceuticals, Inc., West Chicago, IL, US
- OWP Pharmaceuticals, Inc., West Chicago, IL, US
- OWP Pharmaceuticals, Inc., West Chicago, IL, US
Prosecution history
- 06 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Jun 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Feb 2025 — TEAS SECTION 8 & 15 RECEIVED
- 12 Feb 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Jun 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 08 Jan 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Jan 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Jan 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Feb 2019 — REGISTERED-PRINCIPAL REGISTER
- 09 Jan 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Jan 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Jan 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Dec 2018 — USE AMENDMENT FILED
- 07 Jan 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL